The Drug and Poisons Board in the country has immediately suspended the sale and use of children’s cough medicine, under the name Benyline Pediatric cough syrup (Batch No 329304).
This is following what the board has said are claims of disaster in West African countries reported following the use of the popular drug.
PBB said in a Thursday statement that the alert was in response to a recall notice from Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC).
The alert was prompted by NAFDAC’s discovery of an unacceptable high level of diethylene glycol in the product, which poses serious health risks to consumers.
The board is now advising Kenyans to stop using the drug immediately and to report to the nearest health center if anyone who has used it experiences bad symptoms.
